Prosecution Insights
Last updated: August 17, 2026

The Regents of the University of Colorado

59 pending office actions • 41 art units • 57 examiners • 0 of 59 (0%) have an AI response strategy ready • 64 patents granted in the last 365 days

Portfolio Summary

59
Total Pending OAs
46
Non-Final OAs
9
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
0
Due this week
6
Due this month
3
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 30 days (6)Due ≤ 60 days (3)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

30
Hard (51%)
24
Medium (41%)
5
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (7%)
§103 only20 (34%)
§102 only3 (5%)
§112 only4 (7%)
Double-patenting only1 (2%)
Double-patenting + other1 (2%)
Multi-statute (no §101)26 (44%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

35
Life Sciences
59% of docket
1
Information Tech
2% of docket
2
Communications
3% of docket
2
Semiconductors
3% of docket
10
Mechanical / Eng
17% of docket
9
Business / Other
15% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

590 h
Manual time on pending OAs
118 h
Time saved (low, 20%)
206 h
Time saved (mid, 35%)
5.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHAU, LISA N 2 25.0% +17.0%
ANGEBRANNDT, MARTIN J 2 55.4% +34.2%
SHIRSAT, MARCELA 1 73.5% +19.7%
OGUNBIYI, OLUWATOSIN A 1 63.7% +41.5%
SHEN, YANXIN NMN 1 83.3% +27.8%
HALLORAN, THOMAS JAMES 1
YEN, SYLING 1 74.9% +28.0%
GREGORY, BERNARR E 1 90.5% +6.8%
CIRULNICK, EMILY NICOLE 1 25.0% +0.0%
EOM, ROBERT J 1 57.5% +34.7%

Hard Cases (31)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18614952 MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF HADDAD, MAHER M 73d overdue
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof SEAMAN, D MARGARET M 60d overdue
16506235 PERFORMANCE OF TECHNICAL CERAMICS OMORI, MARY I 31d overdue
18546996 Methods And Systems For High-Resolution And High Signal-To-Noise Ratio Imaging Through Generalized Media DEAN, RAY ALEXANDER 11d overdue
17764043 ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICS LU, CHENG 4d overdue
17581307 MOTOR LEARNING AND VAGUS NERVE STIMULATION (VNS) PAIRED WITH MOTOR LEARNING TO TREAT DEMYELINATING DISEASES, CONDITIONS AND DISORDERS LEE, ERICA SHENGKAI 4d overdue
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
18573907 PEROXIDE-ENHANCED GERMICIDAL IRRADIATION FOR THE TREATMENT OF AIRBORNE AND SURFACE-ASSOCIATED CONTAMINANTS CHEN, CHANGRU 12d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 9d
18837842 PLASMON-ENHANCED FLUORESCENCE BIOCHEMICAL SENSORS EOM, ROBERT J 20d
18318926 HYBRID POLYMER/CRYSTAL PHOTOMECHANICAL MATERIALS ANGEBRANNDT, MARTIN J 56d
19143905 SURGICAL INSTRUMENT FOR CONDITIONING LARGE DIAMETER BURR HOLES SHIRSAT, MARCELA
18863566 IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME OGUNBIYI, OLUWATOSIN A
18920752 METHODS AND DEVICES FOR A CONFIGURABLE MEDICAL INFORMATION PLATFORM YEN, SYLING
18285246 CEMENT ADDITIVE FOR RETARDATION OF CEMENT HYDRATION, CEMENT MIXTURES INCLUDING SAME, AND METHODS OF FORMING AND USING SAME CHAU, LISA N
18009618 Holographic Recording Materials and Methods of Making Same ANGEBRANNDT, MARTIN J

Top Art Units

Art UnitApps
1682 3
1797 2
3774 2
1785 2
1631 2
2872 2
1737 2
1794 2
3775 1
1663 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19143905 SURGICAL INSTRUMENT FOR CONDITIONING LARGE DIAMETER BURR HOLES SHIRSAT, MARCELA 3775 §102§103§112 Non-Final OA Pending Jun 27, 2025
18863566 IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME OGUNBIYI, OLUWATOSIN A §102§103§112 Non-Final OA Pending Nov 06, 2024
18925427 HUMAN OSTEOPONTIN PROTEIN PRODUCTION IN PLANT SYSTEMS SHEN, YANXIN NMN 1663 §103§112 Non-Final OA 9d Pending Oct 24, 2024
18858709 MULTIPATH CROSS CORRELATION RADIOMETRY HALLORAN, THOMAS JAMES §112 Non-Final OA Pending Oct 21, 2024
18920752 METHODS AND DEVICES FOR A CONFIGURABLE MEDICAL INFORMATION PLATFORM YEN, SYLING 3687 §103 Non-Final OA Pending Oct 18, 2024
18885581 Inter-Frequency Signal Aiding For Tracking Satellite Navigation Signals GREGORY, BERNARR E 3648 §101§103§112 Non-Final OA Pending Sep 14, 2024
18817015 VENTRICULAR ASSIST ASSEMBLY, SYSTEM, AND METHOD CIRULNICK, EMILY NICOLE 3792 §102§103§112Other Non-Final OA Pending Aug 27, 2024
18837842 PLASMON-ENHANCED FLUORESCENCE BIOCHEMICAL SENSORS EOM, ROBERT J 1797 §103 Non-Final OA 20d Pending Aug 12, 2024
18765795 INTACT PILL DELIVERY SYSTEM THOMAN, EVELYN ANNE §103 Non-Final OA Pending Jul 08, 2024
18750876 RHEOLOGICALLY MODIFIED LIQUID METAL DEVICES AND RELATED SYSTEMS AND METHODS SMOOT, MORIAH SIMONE MCMIL 3791 §103 Non-Final OA Pending Jun 21, 2024
18746960 ELECTRON-ENHANCED METAL OXIDE ATOMIC LAYER DEPOSITION MATTABONI, TIMOTHY JAMES §103 Non-Final OA Pending Jun 18, 2024
18701601 SYSTEM AND METHODS FOR ANALYZING MULTICOMPONENT CELL AND MICROBE SOLUTIONS AND METHODS OF DIAGNOSING BACTEREMIA USING THE SAME BROUGHTON, KATHLEEN M 2661 §102§103§112 Non-Final OA 22d Pending Apr 15, 2024
18627155 COMPOSITIONS AND METHODS FOR REDUCING ADVERSE EFFECTS OF STORAGE, TRANSPORT AND ADMINISTRATION OF ANTIGEN-CONTAINING FORMULATIONS ZHANG SPIERING, DONGXIU 1616 §103 Non-Final OA Pending Apr 04, 2024
18614952 MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF HADDAD, MAHER M 1641 §103§112 Non-Final OA 73d overdue Pending Mar 25, 2024
18601079 LIGHTWEIGHT CALIBRATION METHOD FOR DIRECTION FINDING QUIGLEY, KYLE ROBERT §101§102§103 Non-Final OA Pending Mar 11, 2024
18585791 Crystalline Sp-Sp2 Hybridized Carbon Allotropes through Dynamic Covalent Synthesis KUMAR, SRILAKSHMI K §102§112 Non-Final OA Pending Feb 23, 2024
18686115 IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS EZELUOMBA, MIRIAM NCHEKWUBECHU 1776 §112 Non-Final OA Pending Feb 23, 2024
18685045 CELL-SURFACE ANTIBODY TO A SPECIFIC BIOMARKER OF PANCREATIC BETA-CELLS LOCKARD, JON MCCLELLAND §112 Non-Final OA Pending Feb 20, 2024
18429212 OPHTHALMIC IMPLANT SYSTEM FOR DRUG DELIVERY SHARMA, YASHITA 3774 §102§103 Non-Final OA Pending Jan 31, 2024
18293258 Dynamic Assessment Of Airway Deformation AZIMA, SHAGHAYEGH 2671 §103 Non-Final OA 23d Pending Jan 29, 2024
18412205 REVERSE THERMAL GELS AND THEIR USE AS VASCULAR EMBOLIC REPAIR AGENTS PIPIC, ALMA 1617 §103§112 Non-Final OA Pending Jan 12, 2024
18396386 SURFACE BRACHYTHERAPY DEVICE, APPLICATOR, AND METHODS THEREFOR CASLER, BRIAN L §102§103 Non-Final OA Pending Dec 26, 2023
18573907 PEROXIDE-ENHANCED GERMICIDAL IRRADIATION FOR THE TREATMENT OF AIRBORNE AND SURFACE-ASSOCIATED CONTAMINANTS CHEN, CHANGRU 1796 §102§103 Non-Final OA 12d Pending Dec 22, 2023
18375953 CLUTCH SYSTEM FOR A POWERED PROSTHETIC DEVICE CROWE, RAEGAN NADIA 3774 §102 Non-Final OA Pending Oct 02, 2023
18285246 CEMENT ADDITIVE FOR RETARDATION OF CEMENT HYDRATION, CEMENT MIXTURES INCLUDING SAME, AND METHODS OF FORMING AND USING SAME CHAU, LISA N 1785 §102§103§112 Non-Final OA Pending Sep 30, 2023
18279769 METHODS AND DEVICES FOR NUCLEIC ACID DETECTION JONES, CHRISTINE MICHELLE 1682 §103§112 Final Rejection 13d Pending Sep 01, 2023
18238261 COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) LEE, JIA-HAI 1658 §101§102§103§112DPOther Non-Final OA 75d Pending Aug 25, 2023
18237705 COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF PLATINUM-BASED CHEMOTHERAPEUTIC RESISTANT TUMORS LEE, WILLIAM Y 1623 §102 Non-Final OA Pending Aug 24, 2023
18547348 VIRAL VECTOR-BASED GENE THERAPY FOR OCULAR CONDITIONS LEONARD, ARTHUR S 1631 §103 Non-Final OA Pending Aug 22, 2023
18546996 Methods And Systems For High-Resolution And High Signal-To-Noise Ratio Imaging Through Generalized Media DEAN, RAY ALEXANDER 2872 §103§112 Non-Final OA 11d overdue Pending Aug 18, 2023
18264200 METHODS OF TREATING A SUBJECT EXPOSED TO A TOXIC INHALED CHEMICAL WITH MESNA KELLY-O'NEILL, YOLANDA LYNNETTE 1692 §103 Non-Final OA 17d overdue Pending Aug 03, 2023
18274858 ELECTROLYTE FOR DURABLE DYNAMIC GLASS BASED ON REVERSIBLE METAL ELECTRODEPOSITION KING, GEORGE G 2872 §103 Final Rejection 41d Pending Jul 28, 2023
18359810 Microfluidics Chips Useful in Nanoparticle Preparation and Expandable Pump Network System Useful Therewith GORDON, BRIAN R 1798 §102§103§112 Non-Final OA 76d Pending Jul 26, 2023
18271727 METHODS AND COMPOSITIONS FOR MOLECULAR TRACKING IN INDIVIDUAL CELLS IN VIVO YOUNG, BRIAN ELLIS 1682 §102§103§112 Non-Final OA Pending Jul 11, 2023
18267348 COMPOSITION FOR REVERSIBLE POLYMERIZATION OF THIOESTER AND METHODS THEREOF KAHN, RACHEL 1766 §102§103§112 Non-Final OA Pending Jun 14, 2023
18318926 HYBRID POLYMER/CRYSTAL PHOTOMECHANICAL MATERIALS ANGEBRANNDT, MARTIN J 1737 §103§112 Non-Final OA 56d Pending May 17, 2023
18298967 PULSED ELECTRODEPOSITION FOR REVERSIBLE METAL ELECTRODEPOSITION TO CONTROL METAL FILM MORPHOLOGY AND OPTICAL PROPERTIES DOWNES, NATHANAEL JASON 1794 §103§112 Non-Final OA Pending Apr 11, 2023
18245749 SIGNATURES IN CELL-FREE DNA TO DETECT DISEASE, TRACK TREATMENT RESPONSE, AND INFORM TREATMENT DECISIONS BUCHANAN, BAILEY CHEYENNE 1682 §102§103§112 Final Rejection Pending Mar 17, 2023
18175418 Method for Determining Medication Adherence and Taggants Therefo ALABI, OYELEYE A 1797 §103 Final Rejection 78d overdue Pending Feb 27, 2023
18175225 METHOD OF TREATMENT OF PATIENTS HAVING REDUCED SENSITIVITY TO A BCL-2 INHIBITOR KAUFMAN, CLAIRE M 1674 §102§103§112Other Non-Final OA Pending Feb 27, 2023
18096668 ELECTRON-ENHANCED ATOMIC LAYER DEPOSITION (EE-ALD) METHODS AND DEVICES PREPARED BY SAME MCCLURE, CHRISTINA D 1718 §103 Non-Final OA 56d Pending Jan 13, 2023
18011106 METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS ROSWELL, JESSICA MARIE 1767 §103 Non-Final OA Pending Dec 16, 2022
18009618 Holographic Recording Materials and Methods of Making Same ANGEBRANNDT, MARTIN J 1737 §103 Non-Final OA Pending Dec 09, 2022
18007594 Systems and Methods for Magnetic Buoyancy Enhanced Electrolysis and Boiling Systems WILKINS III, HARRY D 1794 §103 Final Rejection 15d overdue Pending Dec 01, 2022
17997575 MULTISPECIFIC ANTI-FLT3 CHIMERIC ANTIGEN RECEPTORS ABUZEINEH, HANAN ISAM 1633 §103 Final Rejection Pending Oct 31, 2022
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof SEAMAN, D MARGARET M 1625 §102§112 Final Rejection 60d overdue Pending Oct 10, 2022
17953221 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER AGUIRRE, AMANDA L 1626 §102 Non-Final OA Pending Sep 26, 2022
17951504 MOVEABLE SHADING DEVICES AND METHODS OF USE FARINA, MICHAEL VINCENT 2115 §103 Non-Final OA 11d overdue Pending Sep 23, 2022
17704746 METHODS AND COMPOSITIONS COMPRISING A CD93/IGFBP7 BLOCKING AGENT FOR TREATING CANCER ALSOMAIRY, SARAH ABDOALATIF 1646 §112 Final Rejection Pending Mar 25, 2022
17764043 ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICS LU, CHENG 1642 §103§112 Non-Final OA 4d overdue Pending Mar 25, 2022
17634676 POLYURETHANE-REINFORCED HYDROGEL CARDIAC PATCH MILLER, SERENITY A 3771 §103§112 Final Rejection Pending Feb 11, 2022
17581307 MOTOR LEARNING AND VAGUS NERVE STIMULATION (VNS) PAIRED WITH MOTOR LEARNING TO TREAT DEMYELINATING DISEASES, CONDITIONS AND DISORDERS LEE, ERICA SHENGKAI 3796 §103§112 Non-Final OA 4d overdue Pending Jan 21, 2022
17501148 VENOUS ACCESS CATHETERS AND METHODS FOR PORTAL VENOUS SYSTEM CATHETERIZATION PAZ ESTEVEZ, GUILLERMO G 3783 §103 Non-Final OA 114d overdue Pending Oct 14, 2021
17479395 FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME PERREIRA, MELISSA JEAN 1618 DP Non-Final OA Pending Sep 20, 2021
17436581 LIVING STRUCTURAL MATERIAL CHAU, LISA N 1785 §103 Non-Final OA Pending Sep 03, 2021
16960445 3D in vitro Models of Lung Tissue ZHU, JIANJIAN 1631 §103 Non-Final OA 91d overdue Pending Jul 07, 2020
16506235 PERFORMANCE OF TECHNICAL CERAMICS OMORI, MARY I 1784 §103§112 Non-Final OA 31d overdue Pending Jul 09, 2019
18190623 AUTOMATED PLATFORM TO TREAT TRAUMA-INDUCED COAGULOPATHY WITH PERSONALIZED COAGULATION FACTOR CONCENTRATIONS ANDERSON-FEARS, KEENAN NEIL §101§102 Non-Final OA Pending Mar 27, 2023
17972111 DEVICES AND METHODS FOR NUCLEIC ACID EXTRACTION-FREE STI PATHOGEN TESTING CHUNDURU, SURYAPRABHA 1681 §103DP Non-Final OA Pending Oct 24, 2022

Managing The Regents of the University of Colorado's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month